BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2078948)

  • 1. The role of contaminated dialysate in hemodialysis-associated cytokine production.
    Lonnemann G
    Contrib Nephrol; 1990; 86():121-7. PubMed ID: 2078948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dialysate and biocompatibility in hemodialysis].
    Berland Y
    Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-associated induction of cytokines.
    Lonnemann G; Haubitz M; Schindler R
    Blood Purif; 1990; 8(4):214-22. PubMed ID: 2085429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammation in hemodialysis: the role of contaminated dialysate.
    Lonnemann G
    Blood Purif; 2000; 18(3):214-23. PubMed ID: 10859424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients.
    Perez-Garcia R; Anaya F; Chisvert J; Valderrabano F
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164-6. PubMed ID: 8643200
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokine production and nutritional status in hemodialysis patients.
    King AJ; Kehayias JJ; Roubenoff R; Schmid CH; Pereira BJ
    Int J Artif Organs; 1998 Jan; 21(1):4-11. PubMed ID: 9554819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anaphylactic shock in hemodialysis: apropos of 2 cases].
    Bouvier P; Barnouin F; Briat C; Soutif C; Pollini J
    Nephrologie; 1989; 10(1):40-1. PubMed ID: 2716943
    [No Abstract]   [Full Text] [Related]  

  • 8. When good water goes bad: how it happens, clinical consequences and possible solutions.
    Lonnemann G
    Blood Purif; 2004; 22(1):124-9. PubMed ID: 14732820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood components influence cytokine induction by bacterial substances.
    Schindler R; Eichert F; Lepenies J; Frei U
    Blood Purif; 2001; 19(4):380-7. PubMed ID: 11574734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
    Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
    Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
    Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
    Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?
    Nubé MJ; Grooteman MP
    Nephrol Dial Transplant; 2001 Oct; 16(10):1986-91. PubMed ID: 11572884
    [No Abstract]   [Full Text] [Related]  

  • 15. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention of cytokine-inducing substances inside high-flux dialyzers.
    Lufft V; Mahiout A; Shaldon S; Koch KM; Schindler R
    Blood Purif; 1996; 14(1):26-34. PubMed ID: 8718562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine production in haemodiafiltration: a multicentre study.
    Panichi V; De Pietro S; Andreini B; Migliori M; Tessore V; Taccola D; Rindi P; Palla R; Tetta C
    Nephrol Dial Transplant; 1998 Jul; 13(7):1737-44. PubMed ID: 9681721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which level of cytokine production is critical in haemodialysis?
    Cappelli G; DiFelice A; Perrone S; Ballestri M; Bonucchi D; Savazzi AM; Ciuffreda A; Lusvarghi E
    Nephrol Dial Transplant; 1998; 13 Suppl 7():55-60. PubMed ID: 9870439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypersensitivity reactions during hemodialysis. Role of high permeability, retrofiltration and bacterial contamination of the dialysate].
    Montagnac R; Schillinger F; Milcent T; Croix JC
    Nephrologie; 1988; 9(1):29-32. PubMed ID: 3134622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.